Diamyd Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is September - August.

Millions SEK. Fiscal year is Sep - Aug.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	2016 - 2020
Net Income	-169.78	-151.85	-116.07	-103.52	60.05	Upgrade
Depreciation & Amortization	6.5	5.58	4.87	4.38	0.78	Upgrade
Asset Writedown & Restructuring Costs	-	5.41	-	-	-	Upgrade
Other Operating Activities	-5.53	3.77	1.69	-11.61	-145.64	Upgrade
Change in Accounts Receivable	0.02	0.04	0.07	10.1	-19.57	Upgrade
Change in Accounts Payable	-4.64	11.72	-	-	-	Upgrade
Change in Other Net Operating Assets	3.74	-3.85	-1.51	7.43	-5.1	Upgrade
Operating Cash Flow	-169.68	-129.18	-110.96	-93.22	-109.47	Upgrade
Capital Expenditures	-10.05	-8.03	-11.44	-34.65	-4.23	Upgrade
Investment in Securities	27.22	-19.97	39.84	-39.91	-7.66	Upgrade
Other Investing Activities	-	-0	-	6.65	144.41	Upgrade
Investing Cash Flow	17.17	-27.99	28.4	-76.72	132.53	Upgrade
Issuance of Common Stock	315.39	135.21	75.27	150	60	Upgrade
Other Financing Activities	0.93	7.08	11.27	-7.85	-3.28	Upgrade
Financing Cash Flow	316.32	142.28	86.54	142.16	56.72	Upgrade
Foreign Exchange Rate Adjustments	0.62	0.12	3.79	8.17	1.22	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0	Upgrade
Net Cash Flow	164.43	-14.78	7.77	-19.62	81.01	Upgrade
Free Cash Flow	-179.73	-137.21	-122.4	-127.87	-113.69	Upgrade
Free Cash Flow Margin	-138254.61%	-105543.08%	-22418.32%	-28165.42%	-44937.94%	Upgrade
Free Cash Flow Per Share	-1.60	-1.45	-1.56	-1.67	-1.63	Upgrade
Cash Interest Paid	2.63	0.01	0	0.25	0.07	Upgrade
Levered Free Cash Flow	-119.05	-87.83	-80.42	-82.04	-82.18	Upgrade
Unlevered Free Cash Flow	-119.05	-87.82	-80.42	-81.88	-81.9	Upgrade
Change in Working Capital	-0.88	7.91	-1.45	17.52	-24.66	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.